文献速递生殖医学

在人类精子制备培养基中使用孕酮以提高体外受精成功率

Clinical use of progesterone in human sperm preparation media for increasing IVF success.
PubMed 文献 · Reprod Biomed Online · 2023-10-20

本研究在24名男性队列中评估孕酮和神经降压素对精子功能的影响,并在小鼠和猪胚胎模型及4对夫妇中初步测试安全性。孕酮10 µM增加精子与透明质酸结合、超活化运动和酪氨酸磷酸化(均P < 0.05),神经降压素无效;孕酮暴露精子所转移的囊胚均活产,结论认为孕酮有前景但需随机对照试验。

要点

  • 孕酮10 µM增加精子与透明质酸结合、超活化运动和酪氨酸磷酸化(均P < 0.05)。
  • 神经降压素对精子功能无影响(P > 0.05)。
  • 孕酮10 µM通过胚胎安全性测试,小鼠和猪模型受精率或囊胚细胞数增加(均P ≤ 0.03)。

核心结论

  • 在精子制备培养基中添加孕酮作为现有方法辅助手段以提高受精潜力显示出前景。
  • 需要随机对照试验来确定孕酮改善体外受精结局的临床效用。

研究设计与样本

  • 队列研究纳入24名男性,精子经上游法选择后与孕酮或神经降压素(0.1-100 µM)孵育1-4小时。
  • 以盲法评估孕酮10 µM对精子超活化运动、透明质酸结合、酪氨酸磷酸化、顶体反应和氧化DNA损伤的影响。
  • 胚胎安全性测试包括单细胞小鼠胚胎试验、内毒素和菌落计数(n = 3),以及小鼠和猪体外受精临床前模型(各n = 7)和4对夫妇的小型初步人体研究。

主要发现

  • 孕酮10 µM增加精子与透明质酸结合、超活化运动和酪氨酸磷酸化(均P < 0.05)。
  • 神经降压素对精子功能无影响(P > 0.05)。
  • 孕酮10 µM在人胚胎培养基中通过胚胎安全性测试(小鼠胚胎试验、内毒素浓度和菌落计数)。
  • 在临床前体外受精模型中,精子暴露于孕酮10 µM和卵母细胞暴露于孕酮1 µM未产生不利影响,小鼠受精率增加,小鼠和猪囊胚细胞数增加(均P ≤ 0.03)。
  • 在人体中,每一个由暴露于孕酮的精子所产生的移植囊胚均导致活产。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要随机对照试验来确定孕酮改善体外受精结局的临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can the addition of progesterone and neurotensin, molecular agents found in the female reproductive tract, after sperm washing increase the fertilization potential of human spermatozoa? DESIGN: (i) Cohort study of 24 men. Spermatozoa selected by swim-up were incubated in either progesterone or neurotensin (0.1-100 µM) for 1-4 h, and hyperactive motility and binding to hyaluronan (0.1-100 µM) were assessed. The effect of progesterone 10 µM on sperm function was assessed in a blinded manner, including: hyperactive motility, binding to hyaluronan, tyrosine phosphorylation, acrosome reaction and oxidative DNA damage. (i) Embryo safety testing [one-cell mouse embryo assay (MEA), endotoxin and sterility counts (n = 3)] in preclinical embryo models of IVF (murine and porcine, n = 7 each model) and a small preliminary human study (n = 4) of couples undergoing standard IVF with oocytes inseminated with spermatozoa ± 10 µM progesterone. RESULTS: Progesterone 10 µM increased sperm binding to hyaluronan, hyperactive motility and tyrosine phosphorylation (all P < 0.05). Neurotensin had no effect (P > 0.05). Progesterone 10 µM in human embryo culture media passed embryo safety testing (MEA, endotoxin concentration and sterility plate count). In preclinical models of IVF, the exposure of spermatozoa to progesterone 10 µM and oocytes to progesterone 1 µM was not detrimental, and increased the fertilization rate in mice and the blastocyst cell number in mice and pigs (all P ≤ 0.03). In humans, every transferred blastocyst that had been produced from spermatozoa exposed to progesterone resulted in a live birth. CONCLUSION: The addition of progesterone to sperm preparation media shows promise as an adjunct to current methods for increasing fertilization potential. Randomized controlled trials are required to determine the clinical utility of progesterone for improving IVF outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. McPherson NO, Nottle M, McIlfatrick S, et al. Clinical use of progesterone in human sperm preparation media for increasing IVF success. Reprod Biomed Online. 2023. PMID: 38402675. doi:10.1016/j.rbmo.2023.103625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。